1. Improved overall survival in patients developing endocrine toxicity during treatment with nivolumab for advanced non-small cell lung cancer in a prospective study
    M. Albertelli et al, 2024, Journal of Endocrinological Investigation CrossRef
  2. Efficient and sustained IGF-1 expression in the adipose tissue-derived stem cells mediated via a lentiviral vector
    Ting Chen et al, 2015, Journal of Molecular Histology CrossRef
  3. Associations of Insulin and IGFBP-3 with Lung Cancer Susceptibility in Current Smokers
    Gloria Y. F. Ho et al, 2016, Journal of the National Cancer Institute CrossRef
  4. Systemic redox status in lung cancer patients is related to altered glucose metabolism
    Katarzyna Zabłocka-Słowińska et al, 2018, PLOS ONE CrossRef
  5. Associations of glycosylated hemoglobin, pre-diabetes, and type 2 diabetes with incident lung cancer: A large prospective cohort study
    Junjie Hua et al, 2024, Diabetes & Metabolic Syndrome: Clinical Research & Reviews CrossRef
  6. Height in adolescence as a risk factor for glioma subtypes: a nationwide retrospective cohort study of 2.2 million subjects
    Roi Tschernichovsky et al, 2021, Neuro-Oncology CrossRef
  7. Peptide-Based Treatment: A Promising Cancer Therapy
    Yu-Feng Xiao et al, 2015, Journal of Immunology Research CrossRef
  8. The Patient-Derived Cancer Organoids: Promises and Challenges as Platforms for Cancer Discovery
    JuneSung Bae et al, 2022, Cancers CrossRef
  9. Insulin resistance and endometrial cancer risk: A systematic review and meta-analysis
    Adrian V. Hernandez et al, 2015, European Journal of Cancer CrossRef
  10. Genetic association of glycemic traits and antihyperglycemic agent target genes with the risk of lung cancer: A Mendelian randomization study
    Wen Sun et al, 2024, Diabetes & Metabolic Syndrome: Clinical Research & Reviews CrossRef
  11. Insulin-like growth factor (IGF) axis in cancerogenesis
    Aldona Kasprzak et al, 2017, Mutation Research/Reviews in Mutation Research CrossRef
  12. HbA1c-Based Score Model for Predicting Death Risk in Patients with Hepatocellular Carcinoma and Type 2 Diabetes Mellitus
    Lingling He et al, 2017, Journal of Diabetes Research CrossRef
  13. Short- and long-term effect of colorectal cancer targeting peptides conjugated to gold nanoparticles in rats’ liver and colon after single exposure
    Olusola B. Adewale et al, 2022, Toxicological Research CrossRef
  14. The preoperative HbA1c level is an independent prognostic factor for the postoperative survival after resection of non-small cell lung cancer in elderly patients
    Makoto Motoishi et al, 2018, Surgery Today CrossRef
  15. Diabetes mellitus and survival of non‐small cell lung cancer patients after surgery: A comprehensive systematic review and meta‐analysis
    Han‐Yu Deng et al, 2019, Thoracic Cancer CrossRef
  16. Serum Insulin, Glucose, Indices of Insulin Resistance, and Risk of Lung Cancer
    Ilona Argirion et al, 2017, Cancer Epidemiology, Biomarkers & Prevention CrossRef
  17. Assessment of the circulating klotho protein in lung cancer patients
    Judit Pako et al, 2020, Pathology & Oncology Research CrossRef
  18. Glycated Hemoglobin and Cancer Risk in Korean Adults: Results from Korean Genome and Epidemiology Study
    Ji Young Kim et al, 2018, Clinical Nutrition Research CrossRef
  19. Association of Glycosylated Hemoglobin Level and Cancer-Related Mortality in Patients without Diabetes
    Tae Kyung Yoo et al, 2022, Journal of Clinical Medicine CrossRef